Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Psychopharmacology (Berl). 2016 Aug 24;233(21-22):3803–3813. doi: 10.1007/s00213-016-4415-6

Figure 2.

Figure 2

Dopamine D2/3 receptor occupancy for participants with prominent negative symptoms and those with mild or no negative symptoms. Horizontal line denotes the respective mean value.